Willis Investment Counsel Bristol Myers Squibb CO Transaction History

Willis Investment Counsel

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $12.8 Million - $14.2 Million	-287,012 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $1.6 Million - $1.91 Million	35,454 Added 14.09%	287,012 $13.7 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $2.52 Million - $3.27 Million	-51,651 Reduced 17.03%	251,558 $13.1 Million
Q3 2018 Nov 15, 2018	BUY	$55.19 - $62.25 $7.44 Million - $8.39 Million	134,802 Added 80.05%	303,209 $18.8 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $2,071 - $2,582	41 Added 0.02%	168,407 $9.32 Million
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $509,200 - $586,192	-8,498 Reduced 4.8%	168,366 $10.6 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $86,853 - $94,692	-1,449 Reduced 0.81%	176,864 $10.8 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $9.85 Million - $11.4 Million	178,313	178,313 $11.4 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Willis Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Willis Investment Counsel with notifications on news.